SCYNEXIS to Present Commercial Launch Update for BREXAFEMME® (ibrexafungerp tablets)

NEXT STORY
Medicenna Announces Submission of Clinical Trial Application in Australia for a Phase 1/2 Study of MDNA11
PREV STORY
$74 Billion Pain Management Drugs Global Market to 2026 – by Drug Class, Indication, Distribution Channel and Region
Subscribe now to PM360
Get in touch with PM360 Experts On Call

Experts on Call

Ads

You May Also Like

Lixte Biotechnology and City of Hope to Initiate Phase 1b Clinical Trial of Lixte’s Lead Compound LB-100 to Treat Small Cell Lung Cancer

author_avatar
NASDAQ Market News

Genmab Announces European Marketing Authorization for DARZALEX® (Daratumumab) in Combination with Bortezomib, Thalidomide and Dexamethasone in Frontline Multiple Myeloma

author_avatar
NASDAQ Market News

Prospective Data Demonstrates Effective Pain Relief and Improved Function Using Medtronic’s Evolve(SM) Workflow with Spinal Cord Stimulation

author_avatar
NASDAQ Market News